-transparent.png){kind=logo}
Ten patients with reactivated stage D prostatic cancer were treated with the combination therapy of vincristine, ifosfamide and peplomycin (VIP therapy). This treatment gave a good relief of bone pain in 4 out of 8 patients (50%) and improvement of dysuria in 2 out of 6 patients (33%), but objective responses of primary and metastatic lesions were poor. The over-all response rate was 20% by Karnofsky's category of response, 10% by the response criteria of Shida et al., 50% by National Prostatic Cancer Project criteria in the United States and 10% by the response criteria of Koyama and Saito's group. The toxicity of VIP therapy was mild to moderate except for hepatic insufficiency shown in one case.
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
December 1993,
Hinyokika kiyo. Acta urologica Japonica,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
January 1985,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
December 1991,
Hinyokika kiyo. Acta urologica Japonica,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
May 1993,
Cancer,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
March 1992,
Nihon Sanka Fujinka Gakkai zasshi,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
March 1986,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
January 1981,
The Prostate. Supplement,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
January 1988,
Experimental pathology,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
March 1989,
Hinyokika kiyo. Acta urologica Japonica,
T Kazama, and
T Katayama, and
K Umeda, and
T Akiya, and
T Nakada
February 1985,
Hinyokika kiyo. Acta urologica Japonica,
